Steroid Sulfatase Inhibitor-based Solutions for Diverse Health and Performance Applications

This inventive concept leverages the core technology of the original patent to develop innovative solutions for athletic performance, neuromuscular disorders, neurodegenerative diseases, respiratory disorders, and personalized nutrition planning.

The original patent focused on preventing or treating obesity or lipid-related metabolic disorders. However, its core technology has untapped potential for addressing various health and performance challenges. This inventive concept addresses the limitation of the original patent by exploring new applications and use cases.

The new claims encompass a range of solutions, including a wearable device for optimizing energy metabolism and endurance, a treatment for reducing muscle cramping in individuals with neuromuscular disorders, a composition for improving cognitive function in individuals with neurodegenerative diseases, a method for treating respiratory disorders, and a system for personalized nutrition planning. These solutions harness the steroid sulfatase inhibitor's ability to modulate energy metabolism, inflammation, and other physiological processes.

The new claims introduce novel applications and use cases that were not contemplated in the original patent. The inventive step lies in recognizing the potential of the steroid sulfatase inhibitor to address diverse health and performance challenges, and developing innovative solutions that capitalize on this potential.

Alternative embodiments may include oral or transdermal administration of the steroid sulfatase inhibitor, combination therapies with other active ingredients, or integration with wearable devices or mobile applications. Variations could involve adapting the solutions for specific populations, such as children, elderly, or athletes.

The inventive concept has significant commercial potential in the health, wellness, and sports industries. Target markets include athletic performance and recovery, neuromuscular disorder treatment, neurodegenerative disease management, respiratory disease therapy, and personalized nutrition planning. The market size is substantial, with potential revenue streams from pharmaceutical sales, wearable device subscriptions, and nutrition planning services.